Roche purchases shares in tender offer for GenMark Diagnostics, Inc.

Basel, 22 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) and GenMark Diagnostics, Inc. today announced that Roche’s wholly owned subsidiary Geronimo Acquisition Corp. has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of GenMark Diagnostics, Inc. (NASDAQ: GNMK)... Read more

Brooks Automation Announces Fiscal 2021 Second Quarter Earnings Conference Call and Webcast

Brooks Automation Announces Fiscal 2021 Second Quarter Earnings Conference Call and Webcast CHELMSFORD, Mass., April 19, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2021 second quarter which ended on March 31, 2021 on Monday, May 10, 2021 after the market closes. The Company will host a conference call and live webcast to... Read more

Agilent Named One of Singapore’s Best Employers

Company rises in rank from last year SINGAPORE, April 14, 2021  Agilent Technologies Inc. (NYSE: A) today announced that Agilent Singapore has been recognized as one of Singapore’s Best Employers in 2021 for the second year-in-a-row by The Straits Times, a leading Singapore-based newspaper. Specifically, Agilent is ranked among the top 100 companies and fifth out... Read more

Expansion of Lonza’s Automated Robotic Solution for Endotoxin Testing Automates Sustainable Recombinant Factor C Assay

12 Apr 2021 Downloads News Release PDF The PyroTec® PRO Automated Solution combined with the PyroWave® Reader option expands the range of endotoxin testing types available on the platform to now include the PyroGene® Recombinant Factor C assay The addition of the PyroWave® XM Fluorescent Reader complements the existing absorbance readers used in traditional LAL-based assays Full integration with... Read more

FDA Authorizes New High-Throughput, Automated System for Leading COVID-19 Test

The Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit enables laboratories to rapidly scale high-sensitivity PCR testing capacity as schools and employers seek increased testing to support reopening strategies WALTHAM, Mass., April 12, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that the U.S. Food and Drug... Read more

Diasorin To Acquire Luminex Corporation for USD 37.00 per Share or Approximately USD 1.8 Billion

– Provides Access To Proven Luminex Multiplexing Technology And Molecular Testing Solutions To Be Used In Unique Testing Panels, Generating Critical Mass In The Molecular Diagnostics Space – Sets The Ground For New Partnerships And Business Development Opportunities Through Life Science Offerings – Broadens DiaSorin’s Presence In The U.S. – Accelerates Luminex Technology And Solutions’... Read more

Development of the Organ of Corti

Researchers use live tissue confocal microscopy to understand the development of inner ear hair cells Almost every cell in our body contains the same genetic information; yet we develop into complex organisms with each cell having a unique identity and working successfully within its community to create functional organs and complex systems. Dr. David Sprinzak... Read more

Brooks to Participate in the 20th Annual Needham Virtual Healthcare Conference

CHELMSFORD, Mass., April 5, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021 which includes a 40-minute webcast beginning at 12:45 p.m. ET.  The live webcast can be accessed through the Brooks investor relations website at www.brooks.investorroom.com/events.  A... Read more

EUROIMMUN Launches SARS-CoV-2 NeutraLISA Assay to Determine the Neutralizing Capacity of Anti-SARS-CoV-2 Antibodies

CE marked assay based on well-established ELISA technology expands EUROIMMUN’s offerings for labs that seek to understand immune response to COVID-19 WALTHAM, Mass. – April 1, 2021 – EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the SARS-CoV-2 NeutraLISATM assay, a surrogate neutralization test intended for the detection of neutralizing antibodies against SARS-CoV-2,... Read more

Horizon Discovery Extends Gene Modulation Portfolio with Industry First Synthetic Single Guide RNA and Patent Pending dCas9 Repressor for CRISPR Interference

CRISPRi Innovations Provide Expanded Experimental Options and Flexibility For Researchers Facilitating Disease & Drug Research WALTHAM, Mass.–(BUSINESS WIRE)–Mar. 29, 2021– Horizon Discovery, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its gene editing and modulation portfolio is expanding to include a new family of CRISPR modulation (CRISPRmod) reagents for CRISPR interference (CRISPRi). CRISPRi enables scientists... Read more